Summary
The pharmaceutical industry is increasingly seeking new tactics for the structural modification of drug candidates that avoid problems with metabolic susceptibility, or to improve pharmacokinetic properties. Analogues called 'bioisosteres', which mimic the dimensions and...
More information & hyperlinks
| Web resources: | https://www.edandersonchem.org/ |